Blood circulating bacterial DNA in hospitalized old COVID-19 patients

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.

Article  PubMed  PubMed Central  Google Scholar 

Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11:6317.

Article  PubMed  PubMed Central  Google Scholar 

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324:782–93.

Article  PubMed  Google Scholar 

Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol. 2021;31:1–10.

Article  PubMed  Google Scholar 

Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, Meyer CG. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine. 2021;72:103629.

Article  PubMed  PubMed Central  Google Scholar 

Bigdelou B, Sepand MR, Najafikhoshnoo S, Negrete JAT, Sharaf M, Ho JQ, et al. COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes. Front Immunol. 2022;13:890517.

Article  PubMed  PubMed Central  Google Scholar 

Maynou L, Owen R, Konstant-Hambling R, Imam T, Arkill S, Bertfield D, et al. The association between frailty risk and COVID-19-associated all-mortality in hospitalised older people: a national cohort study. Eur Geriatr Med. 2022;13:1149–57.

Article  PubMed  PubMed Central  Google Scholar 

Santesmasses D, Castro JP, Zenin AA, Shindyapina AV, Gerashchenko MV, Zhang B, et al. COVID-19 is an emergent disease of aging. Aging Cell. 2020;19:e13230.

Article  PubMed  PubMed Central  Google Scholar 

Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol. 2021;11:571416.

Article  PubMed  PubMed Central  Google Scholar 

Koduri G, Gokaraju S, Darda M, Warrier V, Duta I, Hayes F, et al. Clinical frailty score as an independent predictor of outcome in COVID-19 hospitalised patients. Eur Geriatr Med. 2021;12:1065–73.

Article  PubMed  PubMed Central  Google Scholar 

Elbadawy HM, Khattab A, El-Agamy DS, Eltahir HM, Alhaddad A, Aljohani FD, Almuzaini TM, Abouzied MM, Aldhafiri A. IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients. J Clin Lab Anal. 2023;37(7):e24881. https://doi.org/10.1002/jcla.24881.

Article  PubMed  PubMed Central  Google Scholar 

Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–6. https://doi.org/10.1002/jmv.26232. (Epub 2020 Sep 3).

Article  PubMed  Google Scholar 

Mihaljevic O, Zivancevic-Simonovic S, Cupurdija V, Marinkovic M, Tubic Vukajlovic J, Markovic A, Stanojevic-Pirkovic M, Milosevic-Djordjevic O. DNA damage in peripheral blood lymphocytes of severely ill COVID-19 patients in relation to inflammatory markers and parameters of hemostasis. Mutagenesis. 2022;37(3–4):203–12. https://doi.org/10.1093/mutage/geac011.

Article  PubMed  Google Scholar 

Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology. 2006;344(1):119–30. https://doi.org/10.1016/j.virol.2005.09.024.

Article  PubMed  Google Scholar 

Sun Y, Wang G, Wang R, Ren L, Yuan Z, Liu Y, Wu Y, Chen R, Chen Y, Diao B. Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19. J Med Microbiol. 2023;72(8).

Trifonova I, Ngoc K, Nikolova M, Todorova Y, Gladnishka T, Christova I. Patterns of cytokine and chemokine expression in peripheral blood of patients with COVID-19 associated with disease severity. Int J Immunopathol Pharmacol. 2023;37:3946320231163681. https://doi.org/10.1177/03946320231163681.

Ho HE, Radigan L, Bongers G, El-Shamy A, Cunningham-Rundles C. Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency. JCI Insight. 2021;6(19):e144777. https://doi.org/10.1172/jci.insight.144777.

Article  PubMed  PubMed Central  Google Scholar 

D’Aquila P, Giacconi R, Malavolta M, Piacenza F, Bürkle A, Villanueva MM, et al. Microbiome in Blood Samples From the General Population Recruited in the MARK-AGE Project: A Pilot Study. Front Microbiol. 2021;12:707515.

Article  PubMed  PubMed Central  Google Scholar 

Gargari G, Mantegazza G, Taverniti V, Del Bo’ C, Bernardi S, Andres-Lacueva C, et al. Bacterial DNAemia is associated with serum zonulin levels in older subjects. Sci Rep. 2021;11:11054.

Mutignani M, Penagini R, Gargari G, Guglielmetti S, Cintolo M, Airoldi A, et al. Blood Bacterial DNA Load and Profiling Differ in Colorectal Cancer Patients Compared to Tumor-Free Controls. Cancers (Basel). 2021;13:6363.

Article  PubMed  Google Scholar 

Giacconi R, D’Aquila P, Malavolta M, Piacenza F, Bürkle A, Moreno Villanueva M, et al. Bacterial DNAemia in older subjects and nonagenarian offspring and association with redox biomarkers: results from MARK-AGE Study. J Gerontol A Biol Sci Med Sci. 2023;78:42–50.

Giacconi R, D’Aquila P, Balietti M, Giuli C, Malavolta M, Piacenza F, et al. Bacterial DNAemia in Alzheimer’s Disease and Mild Cognitive Impairment: Association with Cognitive Decline, Plasma BDNF Levels, and Inflammatory Response. Int J Mol Sci. 2022;24:78.

Sirivongrangson P, Kulvichit W, Payungporn S, Pisitkun T, Chindamporn A, Peerapornratana S, et al. Endotoxemia and circulating bacteriome in severe COVID-19 patients. Intensive Care Med Exp. 2020;8:72.

Article  PubMed  PubMed Central  Google Scholar 

Kitsios GD, Bain W, Al-Yousif N, Duttagupta R, Ahmed AA, McVerry BJ, Morris A. Plasma microbial cell-free DNA load is associated with mortality in patients with COVID-19. Respir Res. 2021;22:24.

Article  PubMed  PubMed Central  Google Scholar 

Hanada S, Pirzadeh M, Carver KY, Deng JC. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol. 2018;9:2640.

Article  PubMed  PubMed Central  Google Scholar 

Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, et al. SARS-CoV-2 Transmission From People Without COVID-19 Symptoms. JAMA Netw Open. 2021;4:e2035057.

Article  PubMed  PubMed Central  Google Scholar 

Boyton RJ, Altmann DM. The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions? Nat Rev Immunol. 2021;21:762–8.

Article  PubMed  PubMed Central  Google Scholar 

Pshenichnaya N, Lizinfeld I, Zhuravlev G. Factors influencing on hospitalization of COVID-19 patients with comorbidity. Int J Infect Dis. 2022;116:S39.

Article  PubMed Central  Google Scholar 

Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, et al. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205.

Article  PubMed  Google Scholar 

Martin-Loeches I, Schultz MJ, Vincent JL, Alvarez-Lerma F, Bos LD, Solé-Violán J, et al. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med. 2017;43:48–58.

Article  PubMed  Google Scholar 

Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. COVID-19 Researchers Group. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27:83–8.

Article  PubMed  Google Scholar 

Davies NG, Jarvis CI, CMMID COVID-19 Working Group, Edmunds WJ, Jewell NP, Diaz-Ordaz K, Keogh RH. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature. 2021;593(7858):270–4. https://doi.org/10.1038/s41586-021-03426-1.

Article  PubMed  PubMed Central  Google Scholar 

Capozzi L, Simone D, Bianco A, Del Sambro L, Rondinone V, Pace L, Manzulli V, Iacobellis M, Parisi A. Emerging Mutations Potentially Related to SARS-CoV-2 Immune Escape: The Case of a Long-Term Patient. Life (Basel). 2021;11(11):1259. https://doi.org/10.3390/life11111259.

PubMed  Google Scholar 

Spinicci M, Graziani L, Tilli M, Nkurunziza J, Vellere I, Borchi B, Mencarini J, Campolmi I, Gori L, Giovannoni L, Amato C, Livi L, Rasero L, Fattirolli F, Marcucci R, Giusti B, Olivotto I, Tomassetti S, Lavorini F, Maggi L, Annunziato F, Marchionni N, Zammarchi L, Bartoloni A. Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes. Viruses. 2022;14(11):2367. https://doi.org/10.3390/v14112367.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81:e6–12.

PubMed  PubMed Central  Google Scholar 

Pardhan S, Wood S, Vaughan M, Trott M. The Risk Of COVID-19 The Risk of COVID-19 Related Hospitalsation, Intensive Care Unit Admission and Mortality in People With Underlying Asthma or COPD: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2021;8:668808.

Article  PubMed  Google Scholar 

Contoli M, Papi A, Tomassetti L, Rizzo P, Vieceli Dalla Sega F, Fortini F, et al. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients. Front Immunol. 2021;12:648004.

Article  PubMed  PubMed Central  Google Scholar 

Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718–24.

Article  PubMed  PubMed Central  Google Scholar 

Magalhães NS, Savino W, Silva PMR, Martins MA, Carvalho VF. Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients. Front Med (Lausanne). 2021;8:644751.

Article  PubMed  Google Scholar 

Al-Emran HM, Rahman S, Hasan MS, Ul Alam R, Islam OK, Anwar A, et al. Microbiome analysis revealing microbial interactions and secondary bacterial infections in COVID-19 patients comorbidly affected by Type 2 diabetes. J Med Virol. 2023;95:e28234.

Article  PubMed 

留言 (0)

沒有登入
gif